Reply to M. Horiguchi et al [Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab as a Result of Adverse Events Lived Significantly Longer Than Patients Who Continued Treatment]
| Autor: | Schadendorf, Dirk, Jiang, Joel, Kelleher, Thomas, Postow, Michael A. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: | |
| Popis: | Korrespondenz zu 10.1200/JCO.2017.76.0983 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|